SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12182249
Source:
http://linkedlifedata.com/resource/pubmed/id/12182249
Search
Subject
(
52
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003009
,
umls-concept:C0011860
,
umls-concept:C0035820
,
umls-concept:C0282443
,
umls-concept:C0680242
,
umls-concept:C1552617
,
umls-concept:C2603343
pubmed:issue
7
pubmed:dateCreated
2002-8-16
pubmed:abstractText
Diabetic nephropathy is the leading cause of end-stage renal disease (ESRD) in Western and Asian countries. Effective antihypertensive therapy reduces the rate of decline in renal function and postpones ESRD in patients with diabetic nephropathy.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7706726
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...
,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Biphenyl Compounds
,
http://linkedlifedata.com/resource/pubmed/chemical/Losartan
,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/irbesartan
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0149-2918
pubmed:author
pubmed-author:RibeiroArtur BAB
,
pubmed-author:ZanellaMaria-TeresaMT
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1019-34
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:12182249-Albuminuria
,
pubmed-meshheading:12182249-Angiotensin Receptor Antagonists
,
pubmed-meshheading:12182249-Angiotensin-Converting Enzyme Inhibitors
,
pubmed-meshheading:12182249-Antihypertensive Agents
,
pubmed-meshheading:12182249-Biphenyl Compounds
,
pubmed-meshheading:12182249-Clinical Trials as Topic
,
pubmed-meshheading:12182249-Diabetes Mellitus, Type 2
,
pubmed-meshheading:12182249-Diabetic Nephropathies
,
pubmed-meshheading:12182249-Humans
,
pubmed-meshheading:12182249-Kidney Failure, Chronic
,
pubmed-meshheading:12182249-Losartan
,
pubmed-meshheading:12182249-Proteinuria
,
pubmed-meshheading:12182249-Renal Circulation
,
pubmed-meshheading:12182249-Tetrazoles
pubmed:year
2002
pubmed:articleTitle
The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies.
pubmed:affiliation
Division of Nephrology, Hospital do Rim e Hipertensão, Federal University of São Paulo, São Paulo, Brazil. tereza.zanella@hrim.com.br
pubmed:publicationType
Journal Article
,
Review
,
Research Support, Non-U.S. Gov't